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Recommended by Joshua P. Metlay
Manybacterialspeciesfunctionasbothcommensalsandpathogens;weusedthisdualnaturetodevelopahigh-throughputmolec-
ular epidemiological approach to identifying bacterial virulence genes. We applied our approach to Group B Streptococcus (GBS).
Three representative commensal and one invasive GBS isolates were selected as tester strains from a population-based collection.
We used microarray-based comparative genomic hybridization to identify open reading frames (ORFs) present in two sequenced
invasive strains, but absent or divergent in tester strains. We screened 23 variable ORFs against 949 GBS isolates using a GBS Li-
brary on a Slide (LOS) microarray platform. Four ORFs occurred more frequently in invasive than commensal isolates, and one
appeared more frequently in commensal isolates. Comparative hybridization using an oligonucleotide microarray, combined with
epidemiologic screening using the LOS microarray platform, enabled rapid identiﬁcation of bacterial genes potentially associated
with pathogenicity.
Copyright © 2008 Lixin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Group B Streptococcus (GBS), or Streptococcus agalactiae,
a common bowel inhabitant, also frequently colonizes the
vagina, urethra, and pharynx asymptomatically. However,
GBS can cause a variety of invasive diseases that occur pri-
marily in neonates, young infants, elderly persons, and preg-
nantwomen[1–3].HostfactorsareclearlyimportantasGBS
diseaseoccursprimarilyinvulnerablepopulations.Nonethe-
less, bacterial virulence factors must also play a role: propen-
sity to cause disease varies by serotype [4], and genetic se-
quence types that cross serotype, which have a high potential
to cause invasive disease, have been identiﬁed [5].
Among the nine known GBS capsular serotypes, sero-
types Ia, III, and V cause the majority of GBS disease in
the United States [1, 6–8]. Studies of the population struc-
ture and the molecular epidemiology of GBS isolates sug-
gest that GBS populations are clonal, but that some strains
may be more virulent than others [9–13]. By pulsed-ﬁeld gel
electrophoresis (PFGE), disease-causing isolates have limited
heterogeneity within a serotype (reviewed in Schuchat, 1998
[2]) while colonizing isolates are quite heterogeneous [14]
within a particular serotype, suggesting that invasive isolates
have distinctive features which enhance pathogenesis. Diﬀer-
ences in virulence are likely related to the presence or ab-
sence of virulence genes [15]. Although advances have been
made in the understanding of classic GBS traits, such as cap-
sular polysaccharide, β-hemolysin, C5a peptidase, and im-
munogenic surface proteins [16–19], our understanding of
the pathogenesis of GBS infections is limited: little is known
about which bacterial genetic factors contribute to virulence
or transmission of pathogenic strains.
The availability of complete and draft genome sequences
ofseveralGBSstrainspresentsanopportunitytogaininsight
into the molecular basis of GBS virulence. Analysis of these
genome sequences conﬁrmed a high level of genetic hetero-
geneity among GBS strains, even of the same serotype [20].
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that often vary among strains and are likely to be the re-
gions where virulence genes reside [21–23]. With thousands
of genes identiﬁed in GBS genomes, the current challenge is
to determine which are important in GBS pathogenesis and
transmission. In a previous study of E. coli,w ep r e s e n t e da n
approach of bacterial gene identiﬁcation and evaluation that
relied on epidemiologic information for selecting isolates for
genomic subtraction and screening of epidemiologically de-
ﬁned collections for evaluation of the signiﬁcance of genes
identiﬁed through genomic subtraction [24]. In this report,
we applied the same principle in a three-step strategy to the
study of GBS. Further, we employed novel microarray plat-
forms that enabled us to systematically identify candidate
genes and evaluate their importance on a large scale.
Genome comparison between pathogenic and non-
pathogenic strains within a species is a powerful strategy for
identifying candidate genes important for virulence [25, 26].
Since none of the currently sequenced GBS genomes are
from commensal isolates, we ﬁrst selected a few representa-
tive colonizing GBS strains from a population-based sam-
ple for comparisons with sequenced pathogenic serotype
III strain (NEM316) and serotype V strain (2306VR), two
serotypes representing the most frequently encountered
disease-causing isolates. We then identiﬁed sequence dif-
ferences and their associated variable genes between se-
lected colonizing and sequenced invasive GBS strains using
comparative genomic hybridization with ﬁne-tiling oligonu-
cleotide microarrays. Lastly, a selected set of variable genes
was screened against a large panel of colonizing and invasive
strains using Library on a Slide microarray to evaluate their
association with disease. Our main objective of this report is
to use GBS as an example to demonstrate and evaluate this
study approach.
2. MATERIALS AND METHODS
2.1. Bacterialstrainsandcultureconditions
Disease-causing and commensal GBS isolates were selected
from various collections obtained from previous epidemi-
ologic studies. Collections included isolates from healthy
male and nonpregnant female college students enrolled at
the University of Michigan [27–30], isolates from symp-
tomatic and asymptomatic pregnant women seen at a Uni-
versity of Michigan Medical Center clinic [31], and isolates
collected from patients through the Wisconsin Invasive Bac-
terialLaboratorySurveillanceSystembetween1998and2002
[32]. Additional isolates from newborns in Texas with early
and late onset disease [8]a sw e l la si s o l a t e sf r o mp r e g n a n t
women with and without GBS disease were obtained from
Dr. Carol J. Baker (Baylor College of Medicine, Houston,
Texas, USA). These strains were broadly grouped into two
categories: invasive isolates from patients with invasive dis-
eases(n = 386)andcolonizingisolatesfromsubjectswithout
any symptomatic diseases (n = 563). GBS strain NEM316
[21], 2603VR [23], and A909 [33] were used as reference
strains. GBS isolates were cultured overnight in Todd-Hewitt
broth (Oxoid) for DNA isolation.
2.2. PFGEandcapsulartyping
PFGE was performed as described previously [30]. Brieﬂy,
GBSDNAwasdigestedwithSmaIandelectrophoresedfor18
hours (initial switch time 4 seconds; ﬁnal switch time 16 sec-
onds) with the CHEF III apparatus (Bio-Rad, Hercules, CA).
Gels werestrained for4h with Vistra Green (AmershamBio-
sciences, Piscataway, NJ, USA) at 4C, and visualized with a
Storm PhosphorImager (Amersham Biosciences, Piscataway,
NJ, USA). PFGE patterns were analyzed using BioNumeric
software (Applied Maths, Kortrijk, Belgium). A dendrogram
was constructed using the unweighted pair group method
with arithmetic means, Dice coeﬃcient, optimization setting
of 1.0%, and a position tolerance of 1.0%. GBS isolates were
classiﬁed into capsular types Ia, Ib, and II–VIII using DNA
dot blot hybridization, as previously described [34].
2.3. GBSoligonucleotidemicroarrayconstruction
Two ﬁne-tiling oligonucleotide microarrays were designed
using the published DNA sequences for serotype III strain
(NEM 316, GenBank accession no. AL732656) and serotype
V strain (2603VR, GenBank accession no. AE009948). The
NEM 316 array consisted of a total of 368,576 32-mer probes
(184,288 pairs) tiling its 2.21Mb genome every 12 bases for
both strands. The 2603VR array consisted of a total 360,040
32-mer probes (180,020 pairs) tiling its 2.16Mb genome ev-
ery 12 bases for both strands. Arrays were designed and con-
structed through custom Array CGH service from Nimble-
Gen (Madison, Wiss, USA) using its maskless array syn-
thesis (MAS) technology. A denser tiling array with shorter
oligonucleotides was usually used in NimbleGen’s two-step
comparative genome sequencing (CGS) [35].
2.4. Comparativegenomehybridizationand
dataacquisition
Comparative genomic hybridization and signal processing
were performed by NimbleGen custom service (NimbleGen
Systems Inc., Madison, Wiss, USA). Brieﬂy, GBS DNA from
four tester strains and two reference strains were broken
downintoseparatepoolsoflowmolecularweightfragments,
labeled independently with cyanine ﬂuorescent dye and each
was hybridized to one NEM316 and to one 2603VR whole-
genometilingarray.SimilartotheAﬀymetrixchips,theshort
oligo GBS arrays were produced by in-slide de novo synthe-
ses. Like Aﬀymetrix chip hybridization, one slide was used
for hybridization per labeled sample. A total of 12 microar-
ray hybridizations were performed. Genomic hybridization
of NEM316 or 2603VR to its own array served as a signal ref-
erence for comparisons with tester strain hybridizations us-
ing the same array. Genome hybridization of one sequenced
genome against the other sequenced genome array was used
for validation purposes. The signal intensity ratios of tester
DNAtoeachreferenceDNAwerecomparedtoidentifyprobe
sequencesabsentordiﬀerentfromthetestergenome.Thera-
tio was generated by normalizing the signal intensity (setting
the median ratio to 1 and the standard deviation to 0.45), di-
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averaging the two strands. Signal ratios were plotted as a
function of their genomic positions and visualized using Sig-
nalMap software from NimbleGen. A custom algorithm was
used to mark the potential variable probe sequence (absent
or diﬀerent in tester genome) based on comparison to a lo-
cal threshold (a 1800bp window). This analysis was also per-
formedbyNimbleGen(seeSupplementaryMaterialavailable
at doi:10.1155/2007/14762 for the analytical algorithm).
2.5. Additionalbioinformaticand
dataanalysismethods
Genome-scale sequence comparisons between genomes of
NEM316 and 2603VR were performed using GenomeComp
[36]. All strain-speciﬁc genetic islands greater than 10bp
were identiﬁed using run parameters set to 0.01, −3, and 1
for expectation value (e), penalty for a mismatch, and re-
ward for a match, respectively. To identify matches of probe
sequences from one ﬁne-tiling oligoarray in the other se-
quenced genome, a custom Bioperl program was used for
local batch blast analyses. The stand alone BLAST program
[37] for Unix operation system was used and the percent
identity of the best hit for each probe within the query
genome was determined. All other data analyses were per-
formed using SAS v9.0 (SAS Institute, Inc Cary, NC, USA)
andSplusv6.1(InsightfulCorporation,Seattle,Wash,USA).
2.6. GBSlibraryonaslidemicroarray
constructionandhybridization
We recently developed a new application of microarray tech-
nology, called Library on a Slide (LOS), for bacterial com-
parative genomics studies [38]. LOS technology combines
dotblothybridizationwiththetechnologyofmicroarraysre-
sulting in glass slides with thousands of bacterial genomes
arrayed. Thus libraries of entire genomes rather than the
sequence of a single genome or set of genes are printed
on the slides. Slides are used to screen large numbers of
strains for the presence of speciﬁc genetic elements of in-
terest. A GBS LOS microarray was created with genomic
DNA from 949GBS isolates sampled from a variety of GBS
collections and various control strains. Genomic DNA was
isolated using a high-throughput sonication-based method
described previously [39]. DNA from GBS strains along
with controls were arrayed in duplicate on Vivid Gene Ar-
ray slides (Pall Life Sciences, Mich, USA) using a VersArray
ChipWriter compact arrayer (Bio-Rad, Calif, USA). Selected
GBS ORFs and four house keeping genes, (alcohol dehydro-
genase (adhP), phenylalanyl tRNA synthetase (pheS), glu-
tamine synthetase (glnA), and glucose kinase (glcK)), were
PCR-ampliﬁed from either strain NEM316 or 2603VR. Puri-
ﬁed PCR products were ﬂuorescein-labeled using BioPrime
DNA labeling kit (Invitrogen, Calif, USA). Each probe was
hybridized with a diﬀerent slide overnight at 68
◦Ci nP e r -
fectHyb Plus hybridization buﬀer (Sigma, Mo, USA). After
washing, ﬂuorescein-labeled probes were detected using an-
tiﬂourescein alkaline phosphatase (Roche, Switzerland) and
alkaline phosphatase kit (TeleChem, Calif, USA). The inten-
sity of each spot was normalized to the intensity of the quan-
tiﬁcation probe (a mixture of four housekeeping genes) to
account for diﬀerences in DNA concentrations at diﬀerent
spots, and compared to the intensity of the positive control
(sequence strain known to contain the gene probe) to deter-
mine presence/absence of the gene fragment in diﬀerent bac-
terial strains using previously established methods [38, 40].
3. RESULTS AND DISCUSSION
3.1. Selectionoftesterstrainsforcomparative
genomicsubtraction
Comparing pathogenic and nonpathogenic strains within a
species can provide critical insights into bacterial pathogen-
esis. However, all sequenced GBS strains are from invasive
diseases. We used molecular epidemiological comparisons to
select representative commensal colonizing GBS isolates for
the comparative genomic hybridization with the highest po-
tential to identify potential pathogenesis-related genes in se-
quenced invasive genomes (strains NEM316 and 2603VR).
We characterized the diversity of 882 colonizing isolates
from a population-based longitudinal study of healthy male
and nonpregnant female college students [28] using PFGE
and serotyping. Clustering analysis by dendrogram was per-
formed on these isolates along with a sample of 35 inva-
sive isolates and sequenced pathogenic strains NEM316 and
2603VR. Based on this analysis, we selected three commensal
isolates that are genetically distant from the two sequenced
genomes but representative of isolates from relatively large
strain clusters that are predominantly of commensal origin.
Isolate 657–461 is a serotype V strain representing the largest
clonal group within our commensal collection. Isolate G617-
061 (serotype III) and G293-061 (serotype II) are from two
additional clusters dominated by colonizing strains. In ad-
dition to these three commensal isolates, one invasive iso-
late, H-19, was chosen for the comparative genomic subtrac-
tion, because it represents the most common clonal type of
the serogroup Ia strain in our analysis. Since serotype clas-
siﬁcation does not necessarily reﬂect genetic distance among
strains [20], we did not select tester strains based solely on
the diﬀerences in serotype. The small number of coloniz-
ing stains chosen here could not and was not intended to
capture the diversity of commensal isolates. It was our ﬁrst
attempt at performing genome-wide comparisons between
colonizing strains and sequenced genomes, so we could pick
gene candidates from a list of several thousands for associa-
tion study using LOS microarrays where large collections of
population-based GBS isolates can be screened.
3.2. Oligonucleotidearrayvalidation
We used shared probe sequences within the two genome
arrays to assess the reproducibility of the comparative ge-
nomic hybridization and used hybridization of one se-
quenced genome against the array of the other sequenced
genome to evaluate the accuracy of the array in assessing se-
quence variation.
Between 184,288 probe pairs on the NEM316 array and
180,020 probe pairs on the 2603VR array, a total of 16,3644 Interdisciplinary Perspectives on Infectious Diseases
Table 1: Sensitivity (probability open reading frame is detected, given it is truly present) and speciﬁcity assessments (probability open
reading frame is not detected, given it is not present) of diﬀerent cutoﬀ values in classifying variable open reading frames using ﬁne-tiling
oligonucleotide genome arrays created from the genomic sequence of group B Streptococcus strains NEM316 and 2603VR.
Reference genome Percentage cutoﬀ point Sensitivity Speciﬁcity
NEM316
20% 0.98 0.91
15% 0.97 0.94
10% 0.96 0.96
2603VR
20% 0.97 0.91
15% 0.95 0.92
10% 0.89 0.96
Table 2: Number (percentage) of variable probe sequences among four tester group B Streptococcus genomes using sequenced strains as a
reference revealed by comparative genomic hybridization.
Reference/sequenced
genomes of invasive
isolates
H1-19 (Ia)
(invasive)
G293-061
(II)
(commensal)
G617-061
(III)
(commensal)
G654-461
(V)
(commensal)
2603VR 327 (15.4%) 320 (15.1%) 72 (3.4%) 278 (13.1%)
NEM316 277 (13.0%) 305 (14.3%) 305 (14.3%) 271 (12.7%)
identical probe pairs (32/32 match) were identiﬁed. Hy-
bridization results for this probe subset from two arrays for
each tester genome were treated as replicas for accessing the
reproducibility of CGH. Hybridization for each probe was
classiﬁed as identical or variable in the tester genome when
comparedtothereferencegenome.Thepercentconcordance
for tester genomes G293-061, H1-19, G617-061, and G654-
461 were 98.75%, 99.50%, 99.88%, and 98.62%, respectively.
The reproducibility was very high even when the raw sig-
nal ratios were examined. The correlation coeﬃcients were
greater than 90% for duplicates.
To evaluate the accuracy of the array in assessing se-
quence variation, we compared results from in silicoanalysis
with the classiﬁcation results from an actual array hybridiza-
tion swap between NEM316 and 2603VR genomes. Almost
all perfectly matched probe sequences were correctly iden-
tiﬁed as identical by hybridization. Only 4 out of 133,520
and 5 out of 133,570 probe sequences were falsely identi-
ﬁed as diﬀerent with NEM316 and 2603VR arrays, respec-
tively. However, 28,673 out of 50,768 (56%) and 25,435 out
of 46,450 (55%) mismatched probe sequences were falsely
identiﬁed as identical with NEM316 and 2603VR arrays, re-
spectively. At the probe level, hybridization has a high sen-
sitivity but low speciﬁcity for detecting conserved probe se-
quences. Nonetheless, the high-density nature of the tiling
array still provides overall sequence variation information
at genome and ORF levels. We visually displayed the CGH
results by plotting hybridization signal ratios of the probes
alongtheirgenomicpositionsandcomparedthemwithanin
silico comparison of NEM316 and 2603VR. The majority of
variable probes (i.e., probes with high reference versus tester
signal ratios) are clustered primarily around strain-speciﬁc
genetic islands identiﬁed by the in silico analysis. To convert
probe-level variation to ORF sequence variation, we calcu-
lated the percentage of variable probes for each ORF (num-
ber of variable probes identiﬁed within an ORF divided by
the total number of probes tiling the ORF). Using diﬀerent
percentage cutoﬀ values in classifying variable ORFs (diver-
gent or absent), the CGH-based data was compared with in
silico analysis (Table 1). For the NEM 316 array, a 15% cutoﬀ
value gave a 2.9% false-negative rate (i.e., ORFs known to be
presentbutclassiﬁedbyhybridizationasabsentorverydiver-
gent)andthebestoverallsensitivityandspeciﬁcity(97%and
94%, resp.). For the 2603VR array, the 20% cutoﬀ point gave
the best overall sensitivity and speciﬁcity (97% and 91%,
resp.). Thus, these two cutoﬀ points were chosen to classify
variable ORFs for the remaining CGH analyses.
Comparative genomic hybridization with ﬁne-tiling 32-
mer oligonucleotide microarrays did not identify all probe
sequence variations in the two reference genomes but reli-
ably identiﬁed variable ORFs using combined hybridization
results of all probes within each ORF.
3.3. Distributionandmappingofvariable
probesequences
CGH using NEM316 and 2603VR genome arrays revealed
that 3.4–15.4% of probe sequences were absent or diver-
gent in the four tester strains (Table 2). This range of diver-
sity is similar to the range of sequence diﬀerences (5% to
15%) recently observed in pairwise comparison of all eight
a v a i l a b l ec o m p l e t eo rd r a f tG B Sg e n o m es e q u e n c e s[ 20]. The
tiling arrays allowed a high-resolution view of genome vari-
ation among comparison strains. Figure 1 displays compara-
tive hybridization results of tester strains against 2603VR by
plotting the reference to tester signal ratios along their ge-
nomic positions. Although the four tester strains represent
four diﬀerent serotypes (Ia, II, III and V), the majority of ab-
sentordivergentprobesequencesinthesestrainsaremapped
tothesamesetofregionsontheNEM316genome,aserotype
III strain. To a lesser extent, the same set of regions on the
2603VR genome covers the majority of the probes that are
absent or divergent across three of the four tester genomes.
The strain G617-061, a serotype III strain, is very similar toLixin Zhang et al. 5
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Figure 1:LocationsofvariableprobessequencesidentiﬁedwithingenomesofgroupBStreptococcusstrains2603VRincomparativegenomic
hybridization using each of the four tester strains of group B Streptococcus.
the serotype V reference strain 2603VR genome, with only
3.4% probes identiﬁed as diﬀerent compared to >13% of
the other tester genomes. Comparison of all eight available
complete or draft GBS genome sequences also demonstrated
that serotype classiﬁcation does not reﬂect the genetic diver-
sity of the GBS [20]. One possible explanation for closely re-
lated strains exhibiting diﬀerent capsules is genetic exchange
of genes determining the capsular type by horizontal gene
transfer.
3.4. NEM316and2603VRORFsabsent/divergentin
testergenomes
Hybridization results from all the probes within each ORF
were used to determine the presence or absence/divergence
in the tester genome using the criteria established through
analyzing control experiments (described above). Among
the 2134 ORFs within the NEM316 genome, 484 (22.7%)
were identiﬁed as variable ORFs because they were classi-
ﬁed as absent/divergent in at least one tester genome. 269
(56%) of them were absent/divergent in four tester genomes,
and 96, 84, and 35 were classiﬁed as absent/divergent in
1, 2, and 3 genomes, respectively. Of 2124 ORFs within
the 2603VR genome, 530 (25%) were identiﬁed as variable
ORFs. Among them, 81, 121, 162, and 166 were classiﬁed as
absent/divergentin4,3,2,and1testergenomes,respectively.
Pairwise genome alignment of the two reference genomes
identiﬁed strain-speciﬁc regions with a total length of 288kb
and 239kb in NEM316 and 2603VR, respectively. Greater
than 95% of the ORFs residing within these strain-speciﬁc
regions were identiﬁed as variable ORFs in our CGH with
fourtestergenomes,representing64%(309/484)ofNEM316
variable ORFs and 52% (275/530) of the 2603VR variable
ORFs. About 80% of variable ORFs identiﬁed by CGH are
located within fourteen putative pathogenicity islands previ-
ously identiﬁed in NEM316 [22].
To investigate which functional groups these variable
ORFs belong to, we classiﬁed ORFs into clusters of ortholo-
gous genes (COGs) [41]. Figure 2 shows the number of vari-
able ORFs in each COG category. Approximately half of the
variable ORFs have not been classiﬁed into COGs and are
of unknown function. The most common classiﬁable vari-
able ORFs belong to the COG category of DNA replica-
tion, recombination, and repair. This is likely attributable
to the presence of integrated phage or plasmids in the ref-
erence genomes. A large number of variable ORFs are pre-
dicted to be involved in transport, regulation, intermediate
metabolism, and cell wall metabolism. These genes may be
important in maintaining the pathogenic life style and trans-
mission of the invasive GBS strains. Genes within these cat-
egories have also been identiﬁed through an in vivo study
in which signature-tagged mutagenesis and a neonatal rat
model were used to identify novel GBS genes implicated in
virulence [42]. Relatively few variable ORFs were found to
be involved in coenzyme transport and metabolism and lipid
transport and metabolism.
3.5. ORFsabsent/divergentinatleasttwotester
genomesofcommensalorigin
ORFs consistently absent/divergent in commensal tester
strains compared to invasive strains are likely virulence gene
candidates. Six ORFs were absent/divergent in all three com-
mensal tester strains, and conserved in the two invasive ref-
erence genomes and the invasive tester strain. We identi-
ﬁed an additional 29 ORFs from the reference genomes that
were absent/divergent in at least two out of the three com-
mensal strains (Table 3). Fifteen of these 35 ORFs are pre-
dictedhypotheticaltobeproteinsofunknownfunction.Sev-
eral ORFs are predicted to be proteins involved in transport,
metabolism, and other metabolic functions. Also included
are two putative lipoproteins and two surface proteins. Gene6 Interdisciplinary Perspectives on Infectious Diseases
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Transcription
Function unknown
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Cell wall/membrane biogenesis
Cell cycle control, mitosis and meiosis
Amino acid transport and metabolism
Inorganic ion transport and metabolism
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energy production and conversion
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Cell motility
Posttranslational modiﬁcation
Signal transduction mechanisms
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Intracellular traﬃcking and secretion
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Secondary metabolism
Figure 2: Number of variable open reading frames in group B Streptococcus strains NEM316 and 2603VR classiﬁed in each of the clusters of
orthologous genes (COG) category plus those not classiﬁed in COG database.
gbs0850 is predicted to encode a ﬁbrinogen binding protein
and is identical to a previously identiﬁed fbsB gene [43, 44].
The best match for gbs0850 in 2603VR is ORF sag0832,
which encodes a diﬀerent variant of the ﬁbrinogen binding
protein. ORFs gbs2015 and gbs2016 are two adjacent genes
with highly similar DNA sequences predicted to encode gly-
cosyl transferases. These two genes are also found together in
the 2603VR genome as sag2060 and sag2061.
While we identiﬁed a large number of variable ORFs,
few were missing in all three or even two commensal tester
strains. Because multiple genetic factors are involved in GBS
virulence and multiple pathogenesis pathways involving dif-
ferentsetsofvirulencegeneslikelyexist,wemightexpectdif-
ferent sets of virulence genes to be identiﬁed when diﬀerent
pairs of invasive and colonizing isolates are compared.
3.6. GBSlibraryonaslidehybridizationand
differentiallydistributedvariableORFs
All variable ORFs are potential virulence gene candidates.
Using a novel GBS LOS microarray platform with a large
collection of GBS isolates, the importance of these variable
ORFscanbeeﬃcientlyevaluated.Wepresentourinitialeval-
uation of 23 of the 35 ORFs identiﬁed above using GBS LOS.
We were not able to synthesize good probes with strong and
speciﬁc signals in our initial attempts for the other 12 vari-
able ORFs because of their small sizes or poor PCR ampliﬁ-
cations. We therefore left them out of this initial LOS screen-
ing. The GBS LOS microarray contained genomic DNA from
949GBSisolatesprintedinduplicate.Amongthem,386were
isolates from patients with invasive diseases and 563 were
commensal colonizing isolates. In addition, the LOS array
contained DNA from various control strains. Table 3 lists
the prevalence of 23 ORF in the overall GBS collection and
their prevalence ratios in invasive strains compared to col-
onizing strains. sag2060, sag2061, sag0832, and gbs0474 ap-
pearedmorefrequentlyininvasiveisolatesthanincolonizing
commensalstrains.Bycontrast,sag0814wasmorefrequently
found among colonizing isolates than invasive isolates.
ORFs sag2060 and sag2061 are two putative glycosyl
transferase genes. Glycosylation plays an important role in
manybiologicalprocessesineukaryotes,andthereisincreas-
ing evidence for a role of glycosylation in bacteria. Many sur-
face expressed bacterial structures such as LPS, LOS, cap-
sule, ﬂagella, and pili in pathogenic bacteria are glycosy-
lated [45–47]. Glycosylation can also be used by bacteria
to inactivate antibiotics [48, 49]. Interestingly, the glycosyl
transferase gene lic2B in Haemophilus inﬂuenzae was found
more frequently among isolates causing otitis media than in
throat isolates from children [50]. Future mechanistic stud-
ies should shed light on the roles of these GBS glycosyl trans-
ferases in pathogenesis.
The sag0832 is predicted to encode a ﬁbrinogen binding
protein.Thisgenehasbeensuggestedtobeanimportantvir-
ulence gene for invasive GBS disease. In a murine model of
sepsis, the wild-type strain was more virulent than the iso-
genic strain with this gene inactivated [44]. sag0832 was also
shown to promote GBS invasion into epithelial cells in vitro
[43]. In addition to the three ORFs encoding known pro-
teins, two ORFs (sag0814 and gbs0474) encoding hypothet-
ical proteins were diﬀerentially distributed between invasive
and colonizing strains. Given the large numbers of ORFs of
noknownfunctionsthatexistinthesequencedgenomes,this
is not surprising. Some of these ORFs probably involve com-
plicated traits that are diﬃcult to observe in laboratory con-
ditions and will be more readily identiﬁed using associationLixin Zhang et al. 7
Table 3:Openreadingframes(ORF)presentininvasivestrainsbutabsentatleastintwooutofthreecommensaltestergroupBStreptococcus
strains by comparative genomic hybridization and their presence among 949GBS isolates and their prevalence ratio between invasive (n =
386) and colonizing (n = 563) isolates.
ORF Probe-positive strains (%) Prevalence ratio (95% CI)(a) Predicted protein
sag0004 524 (55%) 1.1 (0.96–1.22) hypothetical protein
sag0005 706 (74%) 1.0 (0.93–1.09) hypothetical protein
sag0027 941 (99%) 1.0 (0.98–1.00) phosphoribosylaminoimidazole
synthetase
sag0175 692 (73%) 1.0 (0.93–1.09) hypothetical protein
sag0206 590 (62%) 0.9 (0.82–1.01) lipoprotein, putative
sag0253 (b) (b) acetyltransferase, GNAT family
sag0414 927 (98%) 1.0 (0.97–1.01) phosphorylase, Pnp/Udp family, putative
sag0426 — — cupin family protein
sag0427 517 (54%) 1.0 (0.93–1.17) transcriptional regulator, MerR family
sag0700 925 (97%) 1.0 (0.97–1.02)
2-dehydro-3-deoxyphosphogluconate
aldolase/4-hydroxy-2-oxoglutarate
aldolase
sag0814 117 (12%) 0.6 (0.39–0.83) hypothetical protein
sag0815 364 (38%) 0.9 (0.76–1.06) transcriptional regulator, Cro/CI
family-related protein
sag0832 371 (39%) 1.5 (1.29–1.77) ﬁbrinogen binding protein
sag1130 367 (39%) 1.1 (0.90–1.25) hypothetical protein
sag1140 (b) (b) hypothetical protein
sag1207 (b) (b) hypothetical protein
sag1781 (b) (b) primase-related protein
sag1968 87 (9%) 1.1 (0.71–1.61) hypothetical protein
sag1969 907 (96%) 1.0 (0.97–1.03) ribosomal protein L11 methyltransferase
sag1974 (b) (b) MutT/nudix family protein
sag1975 (b) (b) hypothetical protein
sag1976 290 (31%) 0.9 (0.73–1.08) hypothetical protein
sag1994 289 (30%) 1.0 (0.82–1.22) hypothetical protein
sag1999 (b) (b) hypothetical protein
sag2021 395 (42%) 1.2 (1.00–1.36) cell wall surface anchor family protein
sag2026 224 (24%) 1.1 (0.88–1.40) membrane protein, putative
sag2027 (b) (b) ABC transporter, ATP-binding protein
sag2028 (b) (b) hypothetical protein
sag2045 364 (38%) 1.1 (0.90–1.25) DNA topology modulation protein FlaR,
putative
sag2057 (b) (b) leucyl-tRNA synthetase
sag2060 427 (45%) 1.3 (1.13–1.50) glycosyl transferase, family 8
sag2061 437 (46%) 1.2 (1.07–1.41) glycosyl transferase, family 8
sag2088 (b) (b) hypothetical protein
sag2147 687 (72%) 1.0 (0.9–1.06) lipoprotein, putative
gbs0474(c) 270 (28%) 1.5 (1.21–1.80) hypothetical protein
(a) Prevalence with conﬁdence interval not overlapping 1 are considered statistical signiﬁcant.
(b) These ORFs were not screened using LOS mostly because of small sizes.
(c) Exact corresponding gene in strain 2603VR was not found by blast search while it was classiﬁed as present in 2603 VR by CGH.
studies. Interestingly, sag0814 is found more frequently in
commensal strains than in invasive strains. It is possible that
lack of this gene enhances virulence. During the process of
commensal-to-pathogenevolution,bacterianotonlyacquire
virulence genes but also shed genes via deletions [51]. Dele-
tions of genes that facilitate a commensal lifestyle could pro-
vide an additional evolutionary pathway towards virulence.
For example, deletion of lysine decarboxylase gene greatly
enhanced the enterotoxin activity in Shigella in its evolution
[51].8 Interdisciplinary Perspectives on Infectious Diseases
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distributed between invasive and commensal isolates, the
associations of these ORFs with invasive isolates were nei-
ther exclusive nor strong. Such outcomes were not unex-
pected for several reasons. First, we anticipate some degree
of random misclassiﬁcation to decrease the observed associ-
ations because invasive strains can be also commensal, and
noninvasive strains can become opportunistic pathogens.
Second, similar to the existence of several distinct patho-
types within many bacterial pathogens, there may be many
diﬀerent pathotypes within GBS. One virulence gene may
be strongly associated with strains within one speciﬁc GBS
pathotypebuttheassociationislesspronouncedwhenallin-
vasiveisolatesareincludedintheanalysis.Third,GBSpatho-
genesis is determined by not one but many virulence genes
and any one gene may only contribute. We are in the process
of screening these and more variable ORFs on an additional
2000 isolates in order to perform a more deﬁnitive analysis.
In addition, incorporating the population structure of GBS
could potentially enhance our analysis and help with inter-
pretation.
Screening 23 ORFs against 949 isolates also revealed the
striking genome content diversity of GBS. We assigned each
isolate to a genotype based on the presence or absence of all
23 probed examined. A total of 503 genotypes were observed
among 949 isolates. Using this classiﬁcation, strains with the
same PFGE patterns have diﬀerent gene composition. Proﬁl-
ing GBS with a limited number of gene probes could there-
fore provide a highly discriminative typing method.
4. CONCLUSIONS
As increasing numbers of bacterial genomes are sequenced,
postgenome research will focus on identifying virulence-
related genes and the function of these genes. We used
a three-step molecular epidemiological approach employ-
ing two novel microarray platforms, ﬁne-tiling oligonu-
cleotide microarrays, and Library on a Slide to identify bac-
terial virulence genes potentially contributing to GBS dis-
ease. Among hundreds of variable ORFs identiﬁed by CGH,
35 were absent/divergent in two of out three commensal
test strains but present in two invasive reference genomes
and a tester invasive strain. We screened 23 of these ORFs
against 949GBS isolates, and found 5 ORFs that were dif-
ferentially distributed between invasive and commensal iso-
lates. We demonstrated that this approach can rapidly iden-
tify and evaluate bacterial genes potentially associated with
pathogenicity.
In our approach, we adopted microarray-based CGH in-
stead of the traditional genomic subtraction method to iden-
tify genetic diﬀerences between paired commensal and in-
vasive GBS strains. The traditional genomic subtraction ap-
proach can sample only a fraction of strain-speciﬁc genes.
The high-density tiling oligonucleotide array-based CGH al-
lowed us to identify the complete array of DNA sequences
unique to an invasive compared to a commensal GBS iso-
late. A denser and shorter oligonucleotide array design fol-
lowed by a veriﬁcation oligonucleotide array can be used
for identifying even single nucleotide polymorphisms in the
genome [35]. However, CGH-based genome comparisons
depend on the availability of sequenced genomes, and more-
over, strain-speciﬁc genes identiﬁed are conﬁned to the se-
quenced genome. We were not able to detect and identify
potentialvirulencegenesthatarelikelytoexistinotherunse-
quenced pathogenic GBS strains. Given the pan-genome na-
ture of the GBS species where the pool of variable genes are
extremely large [20], future genome comparisons of any two
strains are likely to rely on a cheap and fast direct sequencing
approach such as pyrosequencing [52]. This new approach
will eliminate the limitations of using CGH.
Once a set of candidate genes are identiﬁed by a ge-
nomic comparison, an even more critical step is to evalu-
ate the role that these genes play in disease pathogenesis.
This can be done by large-scale association studies, bioin-
formatic prediction, or biological functional analyses. Bioin-
formatics prediction requires databases with solid structural
and functional information on biological molecules. Func-
tional approaches are often limited to the presence of a char-
acterizable virulence phenotype. Comparing gene frequen-
cies among bacterial isolates collected from diﬀerent sources,
for example, disease-causing and commensal isolates, using
statistical association, can provide insight into the relative
importance of a gene sequence in pathogenesis and trans-
mission. The number of isolates and diversity of the collec-
tions are important in determining the signiﬁcance of obser-
vations made and in ensuring that there is suﬃcient power
to detect associations. Large population-based samples are
required to minimize the identiﬁcation of spurious associa-
tionsthatoftenarisewithsmallsamplecomparisons.Includ-
ing commensal isolates (i.e., nondisease-causing strains) for
study is an integral part of this approach to understand bac-
terial pathogenesis. The LOS microarray platform is a robust
system, adaptable to a wide variety of bacterial pathogens,
for detecting the presence or absence of a candidate gene in
thousands of isolates eﬃciently, thus providing a truly high
throughput system to evaluate genes in the postgenome era.
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